115 related articles for article (PubMed ID: 11896943)
1. Short-term safety of celocentesis for the mother and the fetus.
Makrydimas G; Kaponis A; Skentou C; Lolis D
Ultrasound Obstet Gynecol; 2002 Mar; 19(3):243-5. PubMed ID: 11896943
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of DNA diagnosis of haemoglobinopathies on coelocentesis.
Giambona A; Makrydimas G; Leto F; Damiani G; Jakil MC; Picciotto F; Renda D; Fiorino R; Renda MC; Schillaci G; Gueli-Alletti D; Nicolaides KH; Maggio A
Br J Haematol; 2011 Apr; 153(2):268-72. PubMed ID: 21385172
[TBL] [Abstract][Full Text] [Related]
3. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss.
Caughey AB; Hopkins LM; Norton ME
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):612-6. PubMed ID: 16946222
[TBL] [Abstract][Full Text] [Related]
4. First-trimester fetal reduction to a singleton infant or twins: outcome in relation to the final number and karyotyping before reduction by transabdominal chorionic villus sampling.
Brambati B; Tului L; Camurri L; Guercilena S
Am J Obstet Gynecol; 2004 Dec; 191(6):2035-40. PubMed ID: 15592288
[TBL] [Abstract][Full Text] [Related]
5. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping.
Cederholm M; Haglund B; Axelsson O
BJOG; 2005 Apr; 112(4):394-402. PubMed ID: 15777434
[TBL] [Abstract][Full Text] [Related]
6. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial.
Philip J; Silver RK; Wilson RD; Thom EA; Zachary JM; Mohide P; Mahoney MJ; Simpson JL; Platt LD; Pergament E; Hershey D; Filkins K; Johnson A; Shulman LP; Bang J; MacGregor S; Smith JR; Shaw D; Wapner RJ; Jackson LG;
Obstet Gynecol; 2004 Jun; 103(6):1164-73. PubMed ID: 15172848
[TBL] [Abstract][Full Text] [Related]
7. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation.
Makrydimas G; Sebire NJ; Lolis D; Vlassis N; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Oct; 22(4):368-72. PubMed ID: 14528471
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis.
Elejalde BR; de Elejalde MM; Acuña JM; Thelen D; Trujillo C; Karrmann M
Am J Med Genet; 1990 Feb; 35(2):188-96. PubMed ID: 2309757
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
[TBL] [Abstract][Full Text] [Related]
10. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience.
Odibo AO; Gray DL; Dicke JM; Stamilio DM; Macones GA; Crane JP
Obstet Gynecol; 2008 Mar; 111(3):589-95. PubMed ID: 18310360
[TBL] [Abstract][Full Text] [Related]
12. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
13. Chorionic villus sampling for early prenatal diagnosis at Bhumibol Adulyadej Hospital.
Rueangchainikhom W; Sarapak S; Orungrote N
J Med Assoc Thai; 2008 Jan; 91(1):1-6. PubMed ID: 18386536
[TBL] [Abstract][Full Text] [Related]
14. Psychological distress before and after prenatal invasive karyotyping.
Cederholm M; Sjödén PO; Axelsson O
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):539-45. PubMed ID: 11380290
[TBL] [Abstract][Full Text] [Related]
15. Celocentesis for early prenatal diagnosis of hemoglobinopathy.
Makrydimas G; Damiani G; Jakil C; Cigna V; Orlandi M; Picciotto F; Schillaci G; Cassarà F; Vinciguerra M; Leto F; Giambona A; Maggio A; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Nov; 56(5):672-677. PubMed ID: 32339311
[TBL] [Abstract][Full Text] [Related]
16. Early second trimester (13 to 20 weeks) transabdominal chorionic villus sampling (TA-CVS): a safe and alternative method for both high and low risk populations.
Brambati B; Tului L; Camurri L; Guercilena S
Prenat Diagn; 2002 Oct; 22(10):907-13. PubMed ID: 12378575
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the third trimester amniocentesis for fetal karyotyping in women with fear of pregnancy loss].
Picone O; Fuchs F; Sénat MV; Brisset S; Tachdjian G; Audibert F; Fernandez H; Frydman R
J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):385-91. PubMed ID: 18191913
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous fetal loss after demonstration of a live fetus in the first trimester.
Cashner KA; Christopher CR; Dysert GA
Obstet Gynecol; 1987 Dec; 70(6):827-30. PubMed ID: 3317166
[TBL] [Abstract][Full Text] [Related]
19. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
20. Early fetal size and growth as predictors of adverse outcome.
Pedersen NG; Figueras F; Wøjdemann KR; Tabor A; Gardosi J
Obstet Gynecol; 2008 Oct; 112(4):765-71. PubMed ID: 18827118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
